A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder

J Rural Health. 2021 Jan;37(1):169-171. doi: 10.1111/jrh.12438. Epub 2020 Jun 2.

Authors

Courtenay Gilmore Wilson^{1

2

3}, Melinda Ramage⁴, E Blake Fagan^{1

3}

Affiliations

¹ University of North Carolina (UNC) Health Sciences at Mountain Area Health Education Center (MAHEC), Asheville, North Carolina.
² Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina.
³ School of Medicine, University of North Carolina, Chapel Hill, North Carolina.
⁴ MAHEC Obstetrics and Gynecology, Asheville, North Carolina.

No abstract available

Keywords: COVID-19; buprenorphine/naloxone; opioid use disorder.

MeSH terms

Buprenorphine, Naloxone Drug Combination / therapeutic use*
COVID-19 / epidemiology
Humans
Narcotic Antagonists / therapeutic use*
Opiate Substitution Treatment / methods*
Opioid-Related Disorders / drug therapy*
Pandemics
Primary Health Care / organization & administration*
Rural Health Services / organization & administration*
SARS-CoV-2
Telemedicine / organization & administration
United States / epidemiology

Substances

Buprenorphine, Naloxone Drug Combination
Narcotic Antagonists